• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

食物对缓释5-单硝酸异山梨酯片吸收的影响。

The effect of food on the absorption of slow-release isosorbide-5-mononitrate tablets.

作者信息

Thomson A H, Miller S H, Green S T, Whiting B

机构信息

Department of Materia Medica, University of Glasgow, Stobhill General Hospital, U.K.

出版信息

Eur J Clin Pharmacol. 1988;34(1):47-50. doi: 10.1007/BF01061416.

DOI:10.1007/BF01061416
PMID:3360048
Abstract

The influence of food on the absorption characteristics of slow release isosorbide-5-mononitrate tablets was investigated in 10 normal healthy volunteers. There were no differences in the peak concentration achieved or the area under the curve, but the peak concentration occurred later when the drug was administered after food. The apparent elimination half-life ranged from 4.7 to 10.1 h. Bioavailability of slow-release isosorbide-5-mononitrate is therefore unaffected by food, but there is a slower rate of absorption.

摘要

在10名正常健康志愿者中研究了食物对缓释5-单硝酸异山梨酯片吸收特性的影响。所达到的峰浓度或曲线下面积没有差异,但在进食后给药时,峰浓度出现得较晚。表观消除半衰期为4.7至10.1小时。因此,食物不影响缓释5-单硝酸异山梨酯的生物利用度,但吸收速率较慢。

相似文献

1
The effect of food on the absorption of slow-release isosorbide-5-mononitrate tablets.食物对缓释5-单硝酸异山梨酯片吸收的影响。
Eur J Clin Pharmacol. 1988;34(1):47-50. doi: 10.1007/BF01061416.
2
[Bioavailability of sustained-release and nonsustained-release isosorbide-5-mononitrate].[缓释和非缓释单硝酸异山梨酯的生物利用度]
Arzneimittelforschung. 1989 Oct;39(10):1274-6.
3
[Bioavailability of isosorbide dinitrate and isosorbide-5-mononitrate under steady-state conditions].[稳态条件下硝酸异山梨酯和5-单硝酸异山梨酯的生物利用度]
Dtsch Med Wochenschr. 1985 Nov 22;110(47):1821-5. doi: 10.1055/s-2008-1069095.
4
[Comparative pharmacokinetics and bioavailability of isosorbide dinitrate and its metabolites isosorbide 5- and 2-mononitrate from delayed-release preparations].[硝酸异山梨酯及其代谢产物5-单硝酸异山梨酯和2-单硝酸异山梨酯缓释制剂的比较药代动力学和生物利用度]
Arzneimittelforschung. 1982;32(9):1138-40.
5
[Comparative study of the bioavailability and pharmacokinetics of isosorbide dinitrate formulations in retard form and in standard preparations by determination of isosorbide-5-mononitrate].
Arzneimittelforschung. 1985;35(4):730-4.
6
[Multiple dose pharmacokinetic and bioavailability studies of oral sustained release and conventional formulations of isosorbide-5-mononitrate in healthy volunteers].[健康志愿者中口服单硝酸异山梨酯缓释制剂和普通制剂的多剂量药代动力学及生物利用度研究]
Yao Xue Xue Bao. 1998 May;33(5):373-8.
7
[Bioavailability of isosorbide-5-mononitrate from delayed-action formulations].[延迟作用制剂中5-单硝酸异山梨酯的生物利用度]
Arzneimittelforschung. 1984;34(11):1584-7.
8
Effect of food on the oral bioavailability of isosorbide-5-mononitrate administered as an extended-release tablet.食物对以缓释片形式给药的单硝酸异山梨酯口服生物利用度的影响。
J Clin Pharmacol. 1995 Feb;35(2):151-8. doi: 10.1002/j.1552-4604.1995.tb05004.x.
9
[Pharmacokinetics and bioavailability of a new slow-release isosorbide-5-mononitrate system].[一种新型缓释5-单硝酸异山梨酯制剂的药代动力学及生物利用度]
Cardiologia. 1987 Nov;32(11):1287-91.
10
Sustained-release isosorbide mononitrate (50 mg): optimization of a once-daily dosage form for long-term treatment of angina pectoris.缓释单硝酸异山梨酯(50毫克):用于心绞痛长期治疗的每日一次剂型的优化
Am J Cardiol. 1988 Mar 25;61(9):12E-14E. doi: 10.1016/0002-9149(88)90082-3.

引用本文的文献

1
Long-acting isosorbide mononitrate.长效单硝酸异山梨酯
Drugs. 1999 Jan;57(1):93-9; discussion 100. doi: 10.2165/00003495-199957010-00008.
2
Clinical pharmacokinetics of nitrates.硝酸盐的临床药代动力学
Cardiovasc Drugs Ther. 1994 Oct;8(5):693-9. doi: 10.1007/BF00877116.

本文引用的文献

1
Pharmacokinetics of intravenous and oral isosorbide - 5 - mononitrate.静脉注射和口服单硝酸异山梨酯的药代动力学
Eur J Clin Pharmacol. 1981;20(4):269-75. doi: 10.1007/BF00618777.
2
Isosorbide 5-mononitrate pharmacokinetics in humans.5-单硝酸异山梨酯在人体中的药代动力学。
Biopharm Drug Dispos. 1981 Jul-Sep;2(3):255-63. doi: 10.1002/bdd.2510020306.
3
First data on effects and pharmacokinetics of isosorbide-5-mononitrate in normal man.关于单硝酸异山梨酯在正常人体内的作用及药代动力学的初步数据。
Eur J Clin Pharmacol. 1981;19(6):423-9. doi: 10.1007/BF00548586.
4
[Steady state kinetics of isosorbide-5-mononitrate in patients with coronary disease].[冠心病患者中5-单硝酸异山梨酯的稳态动力学]
Med Welt. 1981 Apr 7;32(14A):517-20.
5
Isosorbide 5-mononitrate and isosorbide 2-mononitrate kinetics after intravenous and oral dosing.静脉注射和口服给药后5-单硝酸异山梨酯和2-单硝酸异山梨酯的动力学
Clin Pharmacol Ther. 1984 Oct;36(4):485-92. doi: 10.1038/clpt.1984.208.
6
Gas-liquid chromatographic determination of isosorbide-5-mononitrate derivatized with perfluorinated anhydrides for pharmacokinetic and bioavailability investigations.用于药代动力学和生物利用度研究的全氟酐衍生化的5-单硝酸异山梨酯的气相色谱测定法
J Chromatogr. 1985 Dec 13;345(2):390-5. doi: 10.1016/0378-4347(85)80177-8.